Pharmaceutical Agents for Targeting Autophagy and Their Applications in Clinics
Open Access
- 11 October 2024
- journal article
- review article
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (10) , 1355
Abstract
Autophagy is the process by which damaged regions of the cytoplasm and intracellular pathogens are degraded. This mechanism often serves an adaptive role in cells, enhancing their survival. It plays a direct or indirect role in the development of various pathological conditions within the body. This phenomenon is common in various malignant diseases, where autophagy is associated with the resistance of transformed cells to chemotherapy. Conversely, abnormal activation of autophagy can trigger cell death, a process often seen in neurodegenerative conditions. Given that dysregulation of autophagy is associated with the progression of numerous pathological conditions, this is of significant interest to the developers of drugs that can effectively modulate autophagy for both basic research and clinical applications. Here, we provide a brief description of the mechanism of macroautophagy, the most prevalent form of autophagy identified in humans. We also discuss the clinical potential of drugs that can modulate autophagy, highlighting their use in combating diseases associated with direct or indirect dysregulation of this essential process.Keywords
Funding Information
- Russian Science Foundation (3-64-10018, 22-14-00353, 075-15-2019-1660)
- Russian Science Foundation (3-64-10018, 22-14-00353, 075-15-2019-1660)
- Ministry of Science and Higher Education of the Russian Federation (3-64-10018, 22-14-00353, 075-15-2019-1660)
This publication has 53 references indexed in Scilit:
- Calpain Inhibitors as Potential Therapeutic Modulators in Neurodegenerative DiseasesNeurochemical Research, 2022
- The effects of metformin on autophagyBiomedicine & Pharmacotherapy, 2021
- Bortezomib for the Treatment of Hematologic Malignancies: 15 Years LaterDrugs in R&D, 2019
- Corynoxine, a Natural Autophagy Enhancer, Promotes the Clearance of Alpha-Synuclein via Akt/mTOR PathwayJournal of Neuroimmune Pharmacology, 2014
- Different effects of Atg2 and Atg18 mutations on Atg8a and Atg9 trafficking during starvation in DrosophilaFEBS Letters, 2013
- Autophagosome formation—The role of ULK1 and Beclin1–PI3KC3 complexes in setting the stageSeminars in Cancer Biology, 2013
- Calpain, Atg5 and Bak play important roles in the crosstalk between apoptosis and autophagy induced by influx of extracellular calciumApoptosis, 2012
- Beclin1 Controls the Levels of p53 by Regulating the Deubiquitination Activity of USP10 and USP13Cell, 2011
- The protective effects and potential mechanism of Calpain inhibitor Calpeptin against focal cerebral ischemia–reperfusion injury in ratsMolecular Biology Reports, 2010
- Crystal Structures of Calpain–E64 and –Leupeptin Inhibitor Complexes Reveal Mobile Loops Gating the Active SiteJournal of Molecular Biology, 2004